Gray Nancy Ryan 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 13, 2022
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-06-10+4,340→ 4,340 totalExercise: $79.29Exp: 2032-06-10→ Common Stock (4,340 underlying) - Award
Common Stock
2022-06-10+1,004→ 4,706 total
Footnotes (2)
- [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.